Summary
Introduction
Cerebral arteries form an integrated vascular network to control the magnitude and distribution of tissue blood flow (Davis, 1993; Segal and Jacobs, 2001) . Under dynamic conditions, tone within this network is regulated by multiple stimuli including changes in tissue metabolism (Harder et al., 1998; Filosa et al., 2006) , humoral/neural stimuli (Furchgott and Zawadzki, 1980; Brayden and Bevan, 1985; Si and Lee, 2002) , and intravascular pressure Segal, 2000) . These stimuli influence tone by altering myosin light chain phosphorylation, a process controlled by global changes in cytosolic Ca 2+ (Davis, 1993; Gallagher et al., 1997; Cole and Welsh, 2011) . Changes in cytosolic Ca 2+ concentration [Ca 2+ ] are principally set by resting membrane potential and steady state Ca 2+ influx through voltagegated Ca 2+ channels Welsh et al., 2000; Welsh et al., 2002) .
In vascular smooth muscle, it is typically asserted that L-type Ca 2+ channels are singularly expressed and thus the only voltagegated Ca 2+ channel of functional importance Bannister et al., 2009) . Recent investigations have begun to reassess this assertion by documenting the additional expression of T-type Ca 2+ channel (Kuo et al., 2010; El-Rahman et al., 2013) . Compared to L-type, T-type channels activate/inactivate at more hyperpolarized membrane potentials and inactivate faster in a Ca 2+ -independent manner (Catterall, 2011) . There are three subtypes of T-type Ca 2+ channels and in vascular smooth muscle both voltage-gated Ca 2+ channels (Ca V )3.1 and Ca V 3.2 are dominantly expressed (El-Rahman et al., 2013) . Past work on vascular T-type channels has centered on isolating the whole-cell conductance and determining its role in myogenic tone development (Kuo et al., 2010; El-Rahman et al., 2013; Harraz and Welsh, 2013) . However, absent from the literature has been a deeper and more comprehensive examination of the T-type channel electrophysiological and regulatory properties. For example, vascular studies have yet to separate Ca V 3.1 from Ca V 3.2 and to determine whether either subtype is modulated by signaling pathways that influence arterial tone development. The latter is particularly prescient as T-type Ca 2+ channels have been reported to be a rich regulatory target in neuronal and cardiac tissues (Li et al., 2012; Sekiguchi et al., 2013) .
The goal of the present study was to isolate and differentiate the T-type Ca 2+ channel conductance in rat cerebral arterial smooth muscle and to determine its sensitivity to protein kinase A (PKA) regulation. In this regard, we isolated vascular smooth muscle cells from rat cerebral arteries and performed a range of experiments using patch clamp electrophysiology and defined pharmacological tools. This study revealed that the vascular Ttype current could be isolated and further subdivided into Ca V 3.1 and Ca V 3.2 components based upon differential sensitivities to Ni 2+ . Subsequent regulatory analysis showed that the Ca V 3.2 component was selectively targeted and suppressed by the PKA signaling pathway. The selective targeting of this T-type conductance could facilitate PKA-mediated dilation by directly lowering cytosolic Ca 2+ or by altering the activity of a Ca 2+ -dependent conductance involved in membrane potential regulation.
Results
This study began by monitoring whole-cell inward currents in cerebral arterial smooth muscle cells bathed in 1.8 mM Ca 2+ or 10 mM Ba 2+ . The former mimics physiological conditions while the latter was designed to accentuate charge flow through open channels (Perez-Reyes, 2003; Nikitina et al., 2007; Li et al., 2010; Harraz and Welsh, 2013) . Stepping from 290 mV to voltages ranging from 250 to +40 mV (10 mV intervals, 300 ms each), we observed a voltage-dependent change in whole-cell current density. In 1.8 mM Ca 2+ , peak inward current was ,6-fold less than that observed in bath solutions containing 10 mM Ba 2+ (Fig. 1A) . Normalized current-voltage (IV) plots showed that Ba 2+ evoked a depolarizing shift (,10-15 mV) in the IVrelationship compared to Ca 2+ (V max , 13.160.5 versus 1.361.4 mV) when overall divalent concentration ([C 2+ ] o ) was maintained constant with MgCl 2 (Fig. 1A,B) . Additionally, Ba 2+ bath solutions significantly slowed the rate of inactivation (Fig. 1C) Whole-cell inward Ba 2+ current reflects simultaneous influx through L-type (Ca V 1.2) and T-type (Ca V 3.1/Ca V 3.2) Ca 2+ channels, the two types present in rat cerebral arterial smooth muscle at the mRNA and protein levels (Kuo et al., 2010; ElRahman et al., 2013) . To separate the two general conductances, we monitored changes in whole-cell current in the presence of increasing concentrations of nifedipine, a dihydropyridine that blocks the vascular Ca V 1.2 splice variant with an IC 50 ,10 nM (Liao et al., 2007) . As expected, nifedipine from 1-200 nM ] o ).
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blocked the inward Ba 2+ current in a dose-dependent manner. At 200 nM, a concentration that should fully abolish Ca V 1.2 activity, we observed a 75-80% block (Fig. 2A) ; the IV relationship of the nifedipine-sensitive and -insensitive components was plotted in Fig. 2B . Normalized IV plots of the sensitive and insensitive components showed that nifedipine induced a 10 mV hyperpolarized shift (V max , 1.961.3 versus 13.460.5 mV; Fig. 2C ). Likewise, voltage ramp experiments revealed that nifedipine-sensitive current displayed a rightward shift in the IV relationship compared to control values (V max 21.060.2 versus 11.760.1 mV), a finding consistent with the isolation of a predominant conductance of T-type channels (Fig. 2D) . Supplementary material Table S1 summarizes the effects of 200 nM nifedipine on the biophysical properties of voltage-gated Ca 2+ channels in cerebral arterial smooth muscle cells, and further compares the characteristics of the isolated Ttype currents to those reported in the literature. Fig. 3A highlights that the residual current lacking sensitivity to 200 nM nifedipine was fully abolished by NNC 55-0396 (Ttype Ca 2+ channel blocker, 1 mM). Similar to the observation of Kuo et al., the same concentration of this presumed T-type channel blocker (NNC 55-0396) significantly attenuated both current components (L-and T-types) when applied alone ( Fig. 3B) (Kuo et al., 2010) . The latter observation highlights the critical importance of applying L-and then T-type channel blockers to circumvent off-targeting effects (El-Rahman et al., 2013) . The temporal kinetics of NNC 55-0396 block varied with concentration with a 20 mM dose eliminating the whole-cell current faster than 5 or 10 mM (Fig. 3C ). Off-target inhibitory effects were also observed with 5 mM mibefradil (Fig. 3D) , a finding consistent with earlier reports (Nikitina et al., 2007; Kuo et al., 2010) .
Additional experiments outlined in Fig. 4 and conducted in the absence or presence of nifedipine confirmed the successful isolation of currents predominantly carried by T-type channels. In the presence of nifedipine (200 nM ] o ) on the voltagedependencies of whole-cell T-type currents in an expression system. Using human embryonic kidney tsA-201 cells expressing human Ca V 3.1 or Ca V 3.2 channels (supplementary material Figs S1, S2), we observed that replacing 1.8 mM Ca 2+ with 10 mM Ba 2+ evoked sizable depolarized shifts (D) in the IV plots (hCa V 3.1 ,15 mV, hCa V 3.2 ,10 mV), activation (hCa V 3.1 ,10 mV, hCa V 3.2 ,6 mV), and steady-state inactivation (hCa V 3.1 ,18 mV, hCa V 3.2 ,7 mV). These observations emphasize the considerable influence that charge carriers exhibit on the electrical characteristics of T-type channels. Note that nifedipine concentrations in the micromolar range did evoke full blockade of the whole-cell current (Fig. 2A) ; this was an expected result as earlier studies have reported T-type channel sensitivity to dihydropyridine in this concentration range (Akaike et al., 1989; Lee et al., 2006) . As depicted in the Fig. 2A inset, the whole-cell Ba 2+ currents consist of two components, one that is more (IC 50 ,13 nM, L-type) and the other less-sensitive (IC 50 ,1.5 mM, Ttype) to nifedipine.
While past studies have reported a T-type conductance in vascular smooth muscle (Nikitina et al., 2007; Kuo et al., 2010; El-Rahman et al., 2013) , they have not attempted to separate among the two constitutive subtypes (i.e. Ca V 3.1 and Ca V 3.2). In cardiac and neuronal studies, separation is routinely achieved by exploiting the differential sensitivity of Ca V 3.1 and Ca V 3.2 channels to Ni 2+ (Niwa et al., 2004; Autret et al., 2005) . In particular, the IC 50 for Ca V 3.2 is as low as 12 mM whereas 20-fold higher concentration is required to achieve 50% block of Ca V 3.1 (IC 50 250 mM, Lee et al., 1999) . Using 50 mM Ni 2+ , a concentration that preferentially blocks Ca V 3.2 channel, we observed a partial suppression (,60%) of nifedipine-insensitive T-type current. The residual conductance, presumably Ca V 3.1, was completely abolished with 1 mM Ni 2+ (Fig. 5A ). Altering the order of agent application (Fig. 5B) , similarly resolved the Ca V 3.2, Ca V 1.2 and Ca V 3.1 components of the whole-cell Ba 2+ current in cerebral arterial smooth muscle cells.
PKA regulation of T-type Ca 2+ channels
We next determined whether T-type Ca 2+ channels are modulated by protein kinases. In particular, we tested the potential regulatory role of PKA, a signaling pathway that limits the global rise in Ca 2+ and induces vasodilatation. Direct activation of the PKA pathway using db-cAMP (200 mM, cell-permeable cAMP derivative) inhibited the currents predominantly carried by T-type channels. Over a comparable time frame, control experiments revealed no significant changes in T-type current amplitude ( Fig. 6A) , an observation similar to earlier reports that T-type currents are rundown-resistant in isolated vascular smooth muscle (Wang et al., 1989; Morita et al., 2002) . Indirect PKA modulation through the upstream activation of adenylyl cyclase and subsequent accumulation of endogenous cAMP (1 mM forskolin; Fig. 6A ) or the b-adrenergic receptor (1 mM isoproterenol; Fig. 6B ) also suppressed T-type currents. Forskolin-mediated inhibition reached a plateau ,15-20 minutes post-incubation (Fig. 6C) , and was partially washable ( We subsequently investigated the effects of PKA inhibitors, PKI 14-22 (1 mM, binds to PKA catalytic subunit thereby displacing the regulatory subunit) or KT5720 (1 mM, competitive inhibitor of ATP thereby rendering the catalytic subunit inactive) on T-type Ca 2+ channels. Under basal conditions, neither inhibitor altered neither peak inward Ba 2+ current nor the voltage-dependence of inactivation/activation (Fig. 7A,B) . Preincubation with KT5720 did, however, limit the ability of forskolin to suppress the nifedipine-insensitive T-type current (Fig. 7C,D) . Interrupting PKA/AKAP interaction with stHt31 (10 mM) similarly prevented forskolin from mediating current suppression. Forskolin-induced T-type inhibition was, however, unaffected in smooth muscle cells pre-incubated with stHt31P (10 mM), the control inactive peptide (Fig. 7E,F) . Summarized responses (percentage inhibition of peak T-type currents) to the different PKA perturbations are collectively presented in supplementary material Fig. S3 .
In a final set of experiments, Ni 2+ was used to determine whether PKA signaling preferentially targets Ca V 3.1 and/or Ca V 3.2 channels. In greater detail, we first suppressed the T-type current with db-cAMP or forskolin and then determined whether 50 mM Ni 2+ (Ca V .3.2 blocker) could eliminate the remaining inward Ba 2+ current. Representative traces in Fig. 8A revealed that following PKA-induced suppression, the residual T-type current displayed insensitivity to Ni 2+ . This insensitivity is particularly evident in Fig. 8B where summary data highlights that Ni 2+ induced suppression of the T-type current dropped from ,55% in control cells to ,6% in cells pre-treated with PKA activators. The lack of a Ni 2+ (50 mM) effect was further noted in Fig. 8C , in which this divalent cation was added 10 minutes postforskolin treatment. Overall, these findings support the view that PKA signaling selectively targets Ca V 3.2 rather than Ca V 3.1 channels.
Discussion
The present study delineated cerebral arterial T-type Ca 2+ channels, investigated their electrophysiological properties, and tested whether this conductance is a target for regulation. Patch clamp electrophysiology revealed that whole-cell Ba 2+ currents, in rat cerebral arterial smooth muscle, could be divided into nifedipine-sensitive and -insensitive components. The latter displayed hyperpolarized IV plots and inactivation/activation characteristics reminiscent of T-type Ca 2+ channels. We further subdivided the nifedipine-insensitive T-type current into Ca V 3.1 and Ca V 3.2 sub-components based on their differential sensitivity to Ni 2+ . This study subsequently showed, for the first time, that T-type channels are targets to PKA signaling modulation. Particularly, PKA stimulation suppressed T-type activity; this suppression was absent when smooth muscle cells were pretreated with PKA inhibitors. Using Ni 2+ to ascertain T-type channel subtype(s) suppressed by PKA, we observed preferential Ca V 3.2 inhibition. In summary, this study demonstrated that Ttype Ca 2+ channels can be electrically isolated, subdivided and are negatively targeted by cerebral vasodilatory signaling pathways.
Background
Voltage-gated Ca 2+ channels are classically divided, based on their activation properties, into high-and low-voltage activated families. The high-voltage activated channels operate at more depolarized potentials and this family encompasses the L-, P/Q, N-and R-types. In comparison, low-voltage activated family activates at more hyperpolarized potentials and T-type channels are the sole members (Catterall, 2011) . Past studies have established that L-type Ca V 1.2 channels function as the primary Ca 2+ influx route in cerebral arterial smooth muscle Bannister et al., 2009) . While important to tone development, recent reports have noted that two T-type Ca 2+ channels are additionally expressed at the mRNA and protein For steady-state inactivation, currents were recorded at +10 mV after prepulses lasting 1.5 s to potentials from 270 to +20 mV. Average normalized data (%I/I max ) were fitted to Eqn 4 to generate curves: control, V 50 inact , 216.460.3 mV; k, 8.760.3; nifedipine, V 50 inact , 234.460.3 mV; k, 9.160.2 (n59). For activation, data were collected from isochronal tail currents evoked by hyperpolarizing test pulses at 290 mV post voltage commands (280 to +40 mV) where the amplitude of the tail current is a measure of the conductance activated during the preceding pulse. Average normalized data (%I/I max ) were fitted to Eqn 3 to generate curves: control, V 50 act , 216.361.9 mV; k, 10.861.3; nifedipine, V 50 act , 225.662.7 mV; k, 11.561.9 (n59). (B) Time dependence of inactivation calculated at five time points following a voltage step from 290 to +10 mV (n57). Steady-state inactivation was achieved at ,1200 ms. *Significant difference from respective control. (C) Averaged effects of nifedipine on the kinetics of voltage-dependent inactivation (time constants, t) calculated from single exponential fits of inactivating currents at voltage steps 230 to +10 mV (n57). (D) Comparison of inactivation time constants (t at 10 mV) of control, nifedipine-sensitive and -insensitive currents (n56). (E) Comparison of activation time constants of nifedipine-sensitive and -insensitive components calculated from standard exponential fitting at +10 mV (n59). levels in cerebral arterial smooth muscle (Kuo et al., 2010; ElRahman et al., 2013) . They specifically include the a 1 subunits of Ca V 3.1 and Ca V 3.2. The 'T' denotes the 'transient' nature of single channels openings (Perez-Reyes, 2003) , and compared to L-type, these channels display faster activation/inactivation characteristics. Past examinations of T-type channels in cerebral arterial smooth muscle have not extended beyond the isolation of a whole-cell conductance despite the known presence (1 mM). Fig. 6 . Effects of PKA activation on T-type Ca 2+ channel currents. (A) Peak current density (pA/pF) of nifedipineinsensitive T-type current at different time points under control conditions (n56) or in cells treated with db-cAMP (cAMP analog, 200 mM, n57) or forskolin (adenylyl cyclase activator, 1 mM, n57). Peak currents (I max ) were assessed every 5 minutes for 15 minutes post-treatment. Insets show representative traces of peak T-type currents before (control) and 15 min post-treatment with db-cAMP or forskolin. (B) Peak current density of the T-type current at different time points under control conditions (n56) or after treatment with isoproterenol (b-adrenergic receptor agonist, 1 mM, n56). *Significant difference from respective zero-time control value. (C) Representative time-course changes in peak current (pA) before and 25 min after forskolin (1 mM). (D) Timecourse changes in normalized peak current (I/I max ) in two groups of cells. The first group was subjected to 1 mM forskolin for 15 min (black, n57) , the second to forskolin for 10 min and then a 5 min wash period (red, n55). *Significant difference from respective time point. (E) Voltage dependence of activation and steady state inactivation of T-type channels before (control, black) and after treatment with 1 mM forskolin (red, n55).
of both Ca V 3.1 and Ca V 3.2 (Kuo et al., 2010; El-Rahman et al., 2013; Harraz and Welsh, 2013) . Additionally, studies have yet to determine if these channels are targets of regulation, particularly by protein kinases known to influence arterial tone development.
Inward current and the isolation of T-type conductances
We began this examination of T-type channels in rat cerebral arterial smooth muscle cells by first documenting inward Ca 2+ current in bath solutions retaining physiological concentrations of Ca 2+ . In keeping with past investigations (Nikitina et al., 2007; Kuo et al., 2010 ), this inward current, which reflects the activity of both L-and T-type channels, displayed voltage-dependent activation and a V 50 of activation and steady-state inactivation of 230 mV and 234 mV, respectively. As peak outward current was ,2.0 pA/pF, 1.8 mM Ca 2+ was subsequently replaced with 10 mM Ba 2+ to augment current magnitude and thus facilitate our ability to isolate and characterize the L-and T-type components. Voltage-dependent inward currents increased to ,6-8 pA/pF as a result of the elevated electrochemical driving force (for the Land T-type) and the enhanced ability of Ba 2+ (2-to 3-fold) to permeate L-type channels (Perez-Reyes, 2003; Li et al., 2010) . While our Ba 2+ based solution amplified the whole-cell current, it also altered the voltage-dependent properties of this inward conductance. Of particular note was the rightward shift in the IV plot, an effect that results from: (1) surface charge screening attributed to the overall extracellular divalent concentration ([C 2+ ] o ) (Perez-Reyes, 2003); and (2) the intrinsic properties of Ba 2+ . Our data emphasizes that both factors contribute additively to the observed depolarized shift. Note that Ba 2+ -based solutions also slowed rate of inactivation, a finding consistent with the loss of Ca 2+ -dependent inactivation of the L-type channels (Nikitina et al., 2007) .
In studies of vascular smooth muscle, investigators have typically employed dihydropyridines to separate among T-and L-type currents (Morita et al., 2002; Nikitina et al., 2007; Kuo et al., 2010; El-Rahman et al., 2013; Smirnov et al., 2013) . Nifedipine is the agent of choice as it blocks the smooth muscle variant of the L-type channels (IC 50 ,10 nM) at concentrations that do not interfere with T-type activity (Akaike et al., 1989; Liao et al., 2007) . When this study employed nifedipine at concentrations 10-to 20-fold above the IC 50 , a dose that should fully abolish Ca V 1.2 activity, we observed ,75-80% reduction in the whole-cell Ba 2+ current. To verify that this dihydroyridineinsensitive current represented T-type activity, biophysical and pharmacological lines of evidence were provided. First, step and ramp protocols revealed that the residual current (in the presence of 200 nM nifedipine) displayed a leftward shifted IV relationship. Next, the nifedipine-insensitive component was fully blocked by T-type Ca 2+ channel inhibitors (Nikitina et al., 2007; Kuo et al., 2010) . Off target effects, however, do impact on the interpretational value of these pharmacological experiments. Finally, Fig. 4 additionally showed that this proposed T-type component exhibited: (1) a hyperpolarized shift in steady-state inactivation and activation; and (2) rates of activation/ inactivation that were consistently faster than the nifedipinesensitive component. It should be noted that while the electrophysiological characteristics of the T-type current in this study were similar to earlier reports in arterial smooth muscle (Nikitina et al., 2007; Kuo et al., 2010, supplementary material Table S1 ), these properties are rightward shifted compared to Ttype channels in other cell types and expression systems (PerezReyes, 2003) . These shifts may be attributed to different T-type splice variants, the cellular model (native cells versus expression systems), and to the experimental conditions/charge carriers employed. The latter was explored in detail and showed to play a profound role in shifting the voltage-dependency of T-type channels. Interestingly, the whole-cell Ba 2+ current could be abolished by nifedipine if concentrations were elevated into the micromolar range, ,500-5000X above the IC 50 for Ca V 1.2. This observation was expected, as past studies have documented that T-type Ca 2+ channels are sensitive to this dihyropyridine in this elevated micromolar concentration range (Akaike et al., 1989; Lee et al., 2006) . This study and previous investigations have shown that nifedipine-insensitive currents, comparable to those in the preceding paragraph, are blocked by broad spectrum T-type inhibitors such as mibefradil, NNC 55-0396, efonidipine and kurtoxin (Kuo et al., 2010; El-Rahman et al., 2013) . While such findings are important, vascular studies have yet to separate among the T-type conductances (i.e. Ca V 3.1 or Ca V 3.2). One means of delineation is to employ a blocker like Ni 2+ , whose IC 50 for Ca V 3.2 (12 mM) is 20-fold lower than that for Ca V 3.1 (250 mM) (Lee et al., 1999) . Using a Ni 2+ concentration (50 mM) sufficient to selectively target Ca V 3.2 channels, we observed ,60% reduction in the nifedipine-insensitive conductance. The residual current, which presumably reflects the remaining Ca V 3.1 channels, was subsequently eliminated in the presence of 1 mM Ni 2+ . Although this study is the first in vascular smooth muscle to exploit Ni 2+ sensitivity, this approach has been used extensively in heart and brain to not only separate among T-type conductances but to ascertain which T-subtypes are targets of cellular regulation (Niwa et al., 2004; Autret et al., 2005) .
Protein kinase regulation of voltage-gated Ca 2+ channels
Past work conducted in cardiac and neuronal tissues has consistently shown that T-type Ca 2+ channels are a rich target for protein kinase regulation (Li et al., 2012; Sekiguchi et al., 2013) . Of particular note is the reported ability of PKA through receptor stimulation to selectively augment Ca V 3.1 or Ca V 3.2 activity in a tissue-dependent manner (Li et al., 2012; Sekiguchi et al., 2013) . In vascular smooth muscle, PKA signaling plays a prominent role in enabling vasodilation through mechanisms involving reductions in cytosolic Ca 2+ . Intriguingly, such observations suggest that if PKA targets vascular T-type conductances, the regulatory effect is more likely to be inhibitory rather than stimulatory. It was within this context that we examined possible PKA-mediated regulation of the Ttype conductance in rat cerebral arterial smooth muscle cells. Overall, we present two sets of observations showing that PKA signaling is inhibitory in this tissue type. First, direct activation of PKA via a cell-permeate cAMP derivative reduced the nifedipine-insensitive T-type inward current by ,60% over a 15-minute incubation period. Second, upstream accumulation of cAMP induced by adenylyl cyclase or b-adrenergic receptor stimulation, elicited a similar suppression of current amplitude. Additional experiments confirmed that T-type inhibition was masked by pre-incubating cells with a PKA inhibitor. This control experiment is important in that it: (1) addresses the target specificity of positive modulators such as forskolin; and (2) indicates that T-type channels are not subject to PKA regulatory control under basal conditions. Recent literature has noted that PKA modulation of voltagegated Ca 2+ channels occurs discretely within compartmental signaling domains (Fuller et al., 2010; Sekiguchi et al., 2013) . Compartmentalization of PKA signaling is achieved through Akinase anchoring proteins (AKAP), scaffolding elements that bring PKA in close proximity to end targets such as neuronal Ca V 3.2 (Sekiguchi et al., 2013) or cardiac Ca V 1.2 (Fuller et al., 2010 ) channels. In this study, we tested for a role of AKAP by 2+ -induced inhibition of T-type channels under control conditions (n58), or in cells pretreated with db-cAMP (200 mM, n55), or forskolin (1 mM, n55). (C) Timecourse changes in peak T-type current in cells treated with forskolin (black, n54) or with forskolin followed by Ni 2+ (red, Ni 2+ was applied on top of forskolin, n56).
introducing stHt31, a peptide inhibitor that interrupts PKA/ AKAP co-association. Consistent with a critical AKAP function, the inclusion of stHt31 but not stHt31P (inactive analog) masked PKA-mediated inhibition. The preceding findings garner greater significance when placed in context with the final set of experiments (Fig. 8) showing that in the presence of PKA activators, Ni 2+ -induced suppression of the T-type conductance is absent. Together, these findings indicate that PKA is not permissively affecting all T-type Ca 2+ channels, but instead targets Ca V 3.2 subtype with the aid of AKAP. Further work is required to mechanistically ascertain how PKA could on the one hand suppress vascular T-type channels but augment the same general conductance in neuronal and cardiac tissue. Perhaps this variance is attributable to tissue-specific splice variants and the subtle changes in protein structure/function that arise from genetic coding alterations. More specifically, alternative splicing could be eliminating and/or introducing new phosphorylation sites. It might also modify PKA access to already existing sites of regulation.
Functional implications
Past studies including our own have argued that T-type Ca 2+ channels play a role in setting arterial tone within the cerebral circulation (Kuo et al., 2010; El-Rahman, 2013) . Of particular note are reports that T-type Ca 2+ channels retain an ability to drive myogenic tone at low intravascular pressures where vessels are hyperpolarized (El-Rahman et al., 2013) . In theory, Ca 2+ influx through T-type Ca 2+ channels could set arterial tone through one of two general mechanisms . First, it could play a 'direct' role in elevating the global concentration of cytosolic Ca 2+ . Such a rise would enhance tone development by augmenting myosin phosphorylation, a process tightly controlled by myosin light chain kinase and phosphatase (Gallagher et al., 1997; Cole and Welsh, 2011) . The second possible mechanism focuses on a more 'indirect' role whereby Ca 2+ influx through T-type channels may locally regulate Ca 2+ -sensitive conductances that influence steady-state membrane potential. Prospective targets include, but are not limited to, Ca 2+ -activated transient receptor potential (e.g. TRPM4) or Ca 2+ -activated chloride (e.g. TMEM16A) channels, both of which have been linked to pressure-induced depolarization (Earley et al., 2004; Bulley et al., 2012) . Irrespective of which mechanism dominates, PKA-induced suppression of T-type conductance would arguably attenuate tone development in rat cerebral arteries.
Summary
In summary, the present study isolated T-type Ca 2+ channels in cerebral arteries, investigated their electrophysiological properties, and tested whether these channels are a target for PKA regulation. Using patch clamp electrophysiology, we delineated a whole-cell current that was insensitive to nifedipine, sensitive to T-type blockers, and displayed characteristics reminiscent of T-type Ca 2+ channels. This Ttype conductance was subdivided into Ca V 3.1 and Ca V 3.2 subcomponents based on differential Ni 2+ sensitivity. Subsequently, we show for the first time that one subtype of T-type channels (Ca V 3.2) is a target to PKA-induced suppression. This selective targeting may implicate Ca V 3.2/PKA signaling in controlling smooth muscle function through direct control of cytosolic Ca 2+ or indirect modulation of membrane potential.
Materials and Methods

Animal procedures
Animal procedures were approved by the Animal Care and Use Committee at the University of Calgary. Briefly, female Sprague-Dawley rats (Rattus norvegicus, 10-12 weeks of age) were euthanized by carbon dioxide asphyxiation. The brain was carefully removed and placed in cold phosphate-buffered (pH 7.4) saline solution containing (in mM): 138 NaCl, 3 KCl, 10 Na 2 HPO 4 , 2 NaH 2 PO 4 , 5 glucose, 0.1 CaCl 2 and 0.1 MgSO 4 . Middle and posterior cerebral arteries were carefully dissected out of surrounding tissue and cut into 2 mm segments.
Isolation of arterial smooth muscle cells
Smooth muscle cells from middle and posterior cerebral arteries were enzymatically isolated as previously described (Anfinogenova et al., 2011) . Briefly, arterial segments were placed in an isolation medium (37˚C, 10 min) containing (in mM): 60 NaCl, 80 Na + glutamate, 5 KCl, 2 MgCl 2 , 10 glucose and 10 HEPES with 1 mg/ml BSA (pH 7.4). Vessels were then exposed to a two-step digestion process that involved: (1) 12-15 min incubation in isolation media (37˚C) containing 0.5 mg/ml papain and 1.5 mg/ml dithioerythritol; and (2) 10 min incubation in isolation medium containing 100 mm Ca 2+ , 0.7 mg/ml type-F collagenase and 0.4 mg/ml type-H collagenase. Tissues were then washed repeatedly with ice-cold isolation medium and triturated with a fire-polished pipette. Liberated cells were stored in ice-cold isolation medium for use the same day within ,6 hours.
Electrophysiological recordings
Conventional patch clamp electrophysiology was used to monitor whole-cell currents of voltage-gated Ca 2+ channel in cerebral arterial smooth muscle cells. Recording electrodes (resistance from 5 to 8 MV when filled with solution) were pulled from borosilicate glass microcapillary tubes (Sutter Instruments, Novato, CA, USA), covered with wax to reduce capacitance, and backfilled with pipette solution containing (in mM): 135 CsCl, 5 Mg-ATP, 10 HEPES, and 10 EGTA (pH 7.2). To attain whole-cell configuration, a pipette was lowered onto an isolated smooth muscle cell, and negative pressure was applied to achieve a gigaohm seal and rupture the membrane. Cells were voltage-clamped (holding membrane potential 260 mV) and equilibrated for at least 5 min in a bath solution containing (in mM): 110 NaCl, 1 CsCl, 10 BaCl 2 , 1.2 MgCl 2 , 10 glucose, and 10 HEPES (pH 7.4). In a supplementary group of cells, Ca 2+ replaced Ba 2+ in the bath solution (in mM): 110 NaCl, 1 CsCl, 1.8 CaCl 2 , 9 MgCl 2 , 10 glucose, and 10 HEPES (pH 7.4). For the experiment depicted in Fig. 1D , bath solutions consisted of (mM): 110 NaCl, 1 CsCl, 1.2 MgCl 2 , 10 glucose, and 10 HEPES + charge carrier (1.8 Ca 2+ , 1.8, 10, 50 or 110 Ba 2+ ). A NaCl-agar salt bridge between the Ag-AgCl reference electrode and the bath solution was used to minimize offset potentials. Whole-cell currents were recorded using an Axopatch 200B patchclamp amplifier (Axon Instruments, Union City, CA, USA), filtered at 1 kHz, digitized at 5 kHz, and were stored on a computer for subsequent offline analysis with Clampfit 10.3 software. Whole-cell capacitance ranged between 14 and 18 pF and was measured with the cancellation circuitry in the voltage-clamp amplifier. Experiments were performed at room temperature (20-22˚C).
To record whole-cell currents, isolated smooth muscle cells were voltageclamped at a holding potential of 260 mV, subjected to a 290 mV pre-pulse (200 ms) and then to 10 voltage steps (300 ms) ranging from 250 to +40 mV (10 mV interval). Current-voltage (IV) relationships were plotted as peak current density (pA/pF) at each voltage step. For voltage ramp recordings, whole-cell currents were monitored using a voltage protocol that ranged from 2100 to +100 mV (0.66 mV/ms). Voltage dependence of steady-state inactivation was assessed by a step protocol: (1) pre-pulse to 290 mV (300 ms), (2) stepping from 270 to +20 mV (10 mV interval, 1.5 s each), (3) hyperpolarizing back to 290 mV (10 ms), and (4) stepping to a test voltage of +10 mV (200 ms). Wholecell currents elicited by the test voltage were normalized to maximal current in order to plot %I/I max versus voltage step. Percentage inactivation was calculated based on current amplitude at different time intervals after peak current development (300, 600, 900, 1200 and 1500 ms). Inactivation time constants (t) were obtained using Clampfit 10.3 software by standard exponential fitting of the inactivating segment of the current. To assess the voltage-dependence of activation, isochronal tail currents were monitored. In particular, cells held at 260 mV were subjected to a pre-pulse (290 mV, 300 ms), voltage steps (280 to +40 mV, 10 mV intervals, 50 ms) and then a final hyperpolarizing test pulse (290 mV, 200 ms) to evoke tail currents. Normalized tail currents (%I/I max ) were plotted versus the voltage step. Activation time constants (t) were obtained by standard exponential fitting of the activating downward segment of the whole-cell Ba 2+ currents.
Experimental protocols
First, voltage step, activation and steady-state inactivation protocols were run on isolated smooth muscle cells bathed in solutions containing 1.8 mM Ca 2+ or 10 mM Ba 2+ . To eliminate the L-type component, whole-cell Ba 2+ currents were subsequently monitored in the presence of different L-type Ca 2+ channel blocker concentrations (nifedipine, 0.01 to 50 mM). Biophysical and pharmacological properties were assessed for the current component that lacked sensitivity to 200 nM nifedipine, a concentration that fully abolish Ca V 1.2 channel activity in vascular smooth muscle (Liao et al., 2007; Kuo et al., 2010) . In keeping with the literature (Lee et al., 1999) , 50 mM Ni 2+ was used to selectively block Ca V 3.2 channels and thus separate this conductance from Ca V 3.1.
To ascertain whether PKA modulation influences T-type Ca 2+ channels, time course changes of nifedipine-insensitive T-type currents were evaluated in the absence (time control) and presence of PKA modulators including: dibutyrylcAMP (a cAMP derivative, 200 mM), forskolin (an adenylyl cyclase activator, 1 mM), isoproterenol (b-adrenergic receptor agonist, 1 mM), PKI 14-22 (protein kinase inhibitor-(14-22)-amide myristoylated; a PKA inhibitor, 1 mM), and KT5720 {(9S,10S,12R)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo(1,2,3-fg:39,29,19-kl) pyrrolo(3,4-i)(1,6)benzodiazocine-10-carboxylic acid hexyl ester; PKA inhibitor; 1 mM}. Subsequent experiments determined the voltage-dependence of activation/steady-state inactivation in the absence (control) and presence of forskolin (1 mM) or KT5720 (1 mM). The forskolin-mediated modulation of T-type Ca 2+ channels was also assessed in cells pre-treated with: (1) KT5720, (2) stHt31 (InCELLect TM AKAP St-Ht31 inhibitor peptide, 10 mM); or (3) stHt31P (control inactive peptide, 10 mM).
Statistical analysis
Data are expressed as means 6 standard error of the mean (s.e.m.), and n indicates the number of cells. Where appropriate, paired t-tests were performed to compare the effects of a given treatment on whole-cell current. *P-values #0.05 were considered statistically significant. The percentage reductions in peak current at various nifedipine concentrations were used to generate concentration-response curves ( Fig. 2A) . Mean values were fitted to the following Hill-Langmuir function:
where PB max is the maximal percentage blockade of peak current, IC 50 is the concentration that produces 50% inhibition, and h is the apparent Hill-Langmuir coefficient for inhibition. Averaged current-voltage relationships were fitted to the following peak Gaussian, third parameter function:
I(V )~I max exp {0:5f(V {V max )=bg
where I max is peak current, V max is V at I max , and b is the slope of the distribution. The voltage dependencies of activation and steady-state inactivation were described with single Boltzmann distributions of the following forms:
Inactivation :
where I max is the maximal activatable current, V 50 is the voltage at which the current is 50% activated or inactivated, and k is the slope (voltage-dependence) of the distribution.
Chemicals and drugs
Nifedipine, NNC 55-0396, mibefradil, NiCl 2 , dibutyryl cyclic-AMP (db-cAMP), isoproterenol and buffer reagents were purchased from Sigma-Aldrich (MO, USA). Forskolin was purchased from EMD Biosciences (CA, USA). Myristoylated PKI 14-22 amide and KT5720 were acquired from Tocris Bioscience (MO, USA). InCELLect TM AKAP St-Ht31 inhibitor peptide and InCELLect TM St-Ht31P control peptide were obtained from Promega (WI, USA).
